Published in Chest on April 01, 2005
Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa (TORNASOL) | NCT03715322
Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Am J Respir Crit Care Med (2014) 2.28
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol (2008) 1.68
Bronchiectasis--diagnosis and treatment. Dtsch Arztebl Int (2011) 1.43
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax (2013) 1.12
Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. BMC Pulm Med (2007) 1.05
Bronchiectasis. Tuberc Respir Dis (Seoul) (2012) 1.04
Clinical applications of pulmonary delivery of antibiotics. Adv Drug Deliv Rev (2014) 0.93
Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol (2015) 0.91
Inhaled therapeutics for prevention and treatment of pneumonia. Expert Opin Drug Saf (2009) 0.89
Bronchiectasis in the Last Five Years: New Developments. J Clin Med (2016) 0.81
Inhaled tobramycin: not just for cystic fibrosis anymore? Chest (2005) 0.77
Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis. Open Respir Med J (2015) 0.77
The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis. Mediators Inflamm (2012) 0.77
Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients. PLoS One (2016) 0.76
Inhaled Antibiotics for Gram-Negative Respiratory Infections. Clin Microbiol Rev (2016) 0.76
The effects of bronchiectasis on asthma exacerbation. Tuberc Respir Dis (Seoul) (2014) 0.75
Non-cystic fibrosis bronchiectasis: review and recent advances. F1000 Med Rep (2009) 0.75
Evaluation effects of nebulized gentamicin in exacerbation of chronic obstructive lung disease. J Res Med Sci (2016) 0.75
Bronchiectasis, part 2: Management. J Respir Dis (2008) 0.75
The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis. Ann Thorac Med (2017) 0.75
Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia. J Crit Care (2009) 1.77
Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. Chest (2004) 1.34
Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers. Antimicrob Agents Chemother (2012) 1.12
Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women. Antimicrob Agents Chemother (2014) 1.04
Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults. Antimicrob Agents Chemother (2009) 0.93
Bronchopulmonary disposition of micafungin in healthy adult volunteers. Antimicrob Agents Chemother (2008) 0.84
Discharge patterns of patients with asthma from the emergency department: a retrospective review. Conn Med (2005) 0.79
Cerebral edema during treatment of diabetic ketoacidosis in an adult with new onset diabetes. Neurocrit Care (2005) 0.77
Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines. Semin Respir Crit Care Med (2009) 0.75
Pancreaticopleural fistula: an unusual cause of pleural effusion. Conn Med (2012) 0.75